Call us today for help! (214) 295-5011
Three promising new mesothelioma treatments have recently been approved by the FDA or are in clinical trials. Approximately 2,500 Americans are diagnosed with mesothelioma each year. Mesothelioma is almost always caused by exposure to asbestos. Common exposures occurred in mines, construction, ships, industrial settings, refineries and chemical plants. Household exposures, hobbies and even home remodeling …
The first new mesothelioma therapy approved by the FDA is based on a trial. In this single-arm STELLAR trial, the median overall survival rate was 18.2 months with patients with unresectable, locally advanced or metastatic malignant pleural mesothelioma who received TTF plus chemotherapy. This combination of treatments comprises the NovoTTF-100L System along with pemetrexed and …
Researchers at Case Western Reserve University School of Medicine, the National Cancer Institute, and Cleveland Clinic, as well as four other institutions, conducted an innovative study that inhibits cancer metastases through the use of epigenetics. Epigenetics is the key Epigenetics is the “study of biological mechanisms that will switch genes on and off.” That is …
It is a proven fact that asbestos exposure can develop into deadly mesothelioma. But how does this happen to healthy cells? Microscopic asbestos fibers are inhaled into the lungs, yet the deadly mesothelioma disease can appear in physically remote mesothelial cells¹. Latest experiments Arti Shukla, Ph.D., associate professor of pathology and laboratory medicine at the …
In a study by researchers led by Dr. Antonio Giordano at the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University and his colleagues at the University of Siena, Italy, a potential new treatment for mesothelioma appears promising. This treatment involves repurposing a drug already approved for the treatment of pinworm parasite infections. …
